<DOC>
	<DOC>NCT00938522</DOC>
	<brief_summary>The purpose of this study is to investigate the effect of cilostazol loading before planned PCI on major adverse cardiac and cerebrovascular events in patients with coronary artery disease.</brief_summary>
	<brief_title>Efficacy Study of Cilostazol Loading in Elective Percutaneous Coronary Intervention</brief_title>
	<detailed_description />
	<mesh_term>Cilostazol</mesh_term>
	<criteria>Patients undergoing elective PCI Presence of coronary lesions amenable to stent Cardiogenic shock Urgent PCI Hypersensitivity to aspirin, clopidogrel, or cilostazol LVEF &lt; 30% or congestive heart failure Bleeding diathesis leukocyte count &lt; 3,000/mm3 and/or platelet count &lt; 100,000/mm3 aspartate aminotransferase or alanine aminotransferase &gt; 3 times upper normal; serum creatinine &gt; 2.0 mg/dl noncardiac disease with a life expectancy &lt; 1 year inability to follow the protocol</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Cilostazol loading</keyword>
	<keyword>Angioplasty, Transluminal, Percutaneous Coronary</keyword>
</DOC>